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Abstract During the last few decades, the use of ultraso-
nography for the detection of fetal abnormalities has
become widespread in many industrialised countries. This
resulted in a shift in timing of the diagnosis of congenital
abnormalities in infants from the neonatal period to the
prenatal period. This has major implications for both
clinicians and the couples involved. In case of ultrasound
diagnosis of fetal anomaly, there are several options for the
obstetric management, ranging from standard care to non-
aggressive care and termination of pregnancy. This essay
explores the context of both clinical and parental decision
making after ultrasound diagnosis of fetal abnormality, with
emphasis on the Dutch situation. While normal findings at
ultrasound examination have strong beneficial psycholog-
ical effects on the pregnant woman and her partner, the
couple is often ill prepared for bad news about the health of
their unborn child in the case of abnormal findings. This is,
in particular, true in settings where ultrasonography for the
detection of fetal abnormalities is offered as an integral part
of antenatal care without appropriate counselling. An
important question is to what extent the couple should be
supported in decision making when a fetal abnormality is
diagnosed. In this context, the parental perception of having
a choice varies markedly. When parents consider end-of-life
decisions, they experience both ambivalent and emotional
feelings. On the one hand, they are committed to their
pregnancy, while on the other hand, they want to protect
their child, themselves and the family from the burden of
severe disability. These complex parental reactions have
implications for the counselling strategy.
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Congenital abnormalities
Congenital abnormalities are the main cause of infant death
in industrialised countries [1, 2]. Congenital abnormalities
are frequently diagnosed before birth, as many of the major
fetal abnormalities can be detected by a prenatal ultrasound
examination [3–5]. From data derived from a routine
ultrasound screening setting of an unselected population
in Oxford [6], the estimated birth prevalence of infants with
abnormalities is 2.2% (Fig. 1). Just more than half (55%) of
them were diagnosed with abnormalities that were identi-
fied prenatally. Currently, ultrasound scanning is considered
the most important tool for prenatal diagnosis of fetal
congenital abnormalities. It detects the majority but
certainly not all of the fetal abnormalities [6]. In specialist
centres for prenatal diagnosis, detection rates of fetal
abnormalities range from 80 to 95% [4, 7]. Detection rates
in screening settings are probably lower. The detection rates
also depend on the nature, type and numbers of abnormal-
ities. For example, prenatal detection rates of neural tube
defects approximate 98% while those of congenital heart
defects are about 38%. Apart from the nature of the fetal
abnormality, maternal obesity has a considerable impact on
detection rates [8].
The study in Oxford also addressed the overall impact of
prenatal ultrasound diagnosis in terms of numbers of infants
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born with conditions that result in mortality or severe
morbidity (Fig. 1) [6]. In fact, when severe congenital
abnormalities are detected prenatally, termination of preg-
nancy is an option for the couple involved. In the majority
of end-of-life decisions in the prenatal period, suspicion of
fetal abnormality was first aroused after ultrasound scan [6].
Hence, the practice of ultrasound scanning is closely related
to that of end-of-life decisions.
Developments in fetal ultrasound
Since the early sixties, when the first ultrasound images of
the fetus were made, ultrasound has evolved into the most
important diagnostic tool in fetal medicine [9]. First, only
static images of the fetus were available. In 1977, real-time
scanning was introduced, which allowed for moving
images of the fetus. Soon thereafter, ultrasound became
widely available in clinical practice. In a short period of
time, a myriad of reports on both normal and abnormal
anatomy of the fetus appeared in the medical literature.
Nowadays, routine ultrasound examination during preg-
nancy is an integral part of antenatal care in most
industrialised countries [9–11]. Routine ultrasound exami-
nation typically includes a dating scan in the first trimester
of pregnancy and a fetal abnormality scan at approximately
18–20 weeks’ gestation [9].
In countries with a routine ultrasound screening policy,
more than half of all congenital abnormalities are diagnosed
prenatally, including 74% of the major abnormalities (i.e.
abnormalities that have implications for the infant’s health)
and 46% of the minor abnormalities (i.e. abnormalities that
have no implications for the infant’s health) [6, 12].
Ultrasound screening
From the perspective of public health, the potential benefits
and limitations of ultrasound screening for fetal abnormal-
ities have been debated extensively [4, 9]. To date, reports
on the benefits of ultrasound screening for the detection of
both lethal and non-lethal abnormalities among unselected
populations are inconclusive [13]. Randomised controlled
trials have been done but have used perinatal mortality and
morbidity as outcome variables. Moreover, in research
settings, there was a wide variation in expertise levels of
sonographers. The interpretation of the research findings is
further impeded by the time period of the studies being
conducted; ultrasound nowadays is more advanced than in
former days [10]. These methodological problems are
reflected in an enormous variation of reported overall
sensitivity of the detection of congenital abnormalities,
which ranges between 14 and 96% [3–5, 13]. Apart from
these methodological flaws, the use of perinatal mortality
and morbidity as the most important outcome variables is
questionable [10]. Other outcome variables, such as
improved information of pregnant women about the health
status of their offspring, enhanced care for the affected
neonate, better fetal–maternal bonding, the potential pre-
vention of a ‘wrongful life’ are relevant as well [13]. These
issues warrant additional questions about the aim of
screening. The answer to these questions should not only
Congenital abnormality at birth 
n=725 (2.2%) 
  Lethal malformations1   110 (15%) 
  Possible survival and long-term morbidity2 398 (55%) 




 Alive4        176 (44%) 
 Termination of pregnancy     169 (43%)  
 Death in utero/spontaneous abortion       25 (  6%) 
 Neonatal death        20 (  5%) 
 Stillbirth           6 (  2%) 
 
Not diagnosed prenatally 
n=329 (45.4%) 
 
  Not amenable for prenatal diagnosis5         129 (39%) 
  Difficult to diagnose prenatally6         35 (10%)  
  Missed on routine abnormality scan           76 (23%) 
  Scan not done/not done at appropriate time  59 (18%) 
  Scan details not known            30 (  9%) 
33,376 births
Fig. 1 Overview of prenatal detection of congenital abnormality
when prenatal screening is offered routinely in an unselected
population in Oxford, 1991_1995; births included all births over
20 weeks and all pregnancies terminated because of fetal abnormality
detected at any age of gestation. 1, e.g. anencephaly, trisomy 13,
trisomy 18, hypoplastic left heart, renal agenesis, Meckel Gruber
syndrome; 2, e.g. spina bifida, hydrocephalus, Down’s syndrome,
complex cardiac malformations, diaphragmatic hernia, abdominal wall
defects; 3, e.g. non-complex cardia malformations, facial clefts, club
foot, hypospadia; 4, two infants died after the neonatal period; 5, e.g.
skin abnormalities, hypospadia, congenital dislocation of the hip, cleft
palate, atrial–septal defect; 6, e.g. tracheo-oesofageal fistula or fistula,
coarctation of aorta, polydactyly, ambiguous genitalia
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pertain to medical data but should also incorporate moral
choices [10, 11, 14].
In The Netherlands, the implementation of ultrasound
screening into clinical practice has been a matter of strong
debate [11]. Initially, the government decided that ultra-
sound is only to be offered for ‘genetic’ indications, i.e.
targeted at women at increased risk of congenital abnor-
malities in offspring [11]. This policy should be seen within
the Dutch sociocultural context. Dutch law typically bans
population screening, unless certain conditions are fulfilled,
such as the availability of effective treatment for the
outcome of interest [11]. In the context of prenatal
screening for fetal abnormalities, abortion is not considered
as an “effective” modality. Furthermore, there were con-
cerns about the implications of prenatal screening in terms
of medicalisation of the pregnancy and regarding the
position of handicapped people in the society at large
[11]. Only recently, Dutch law became more compliant,
which resulted in a trend towards offering all pregnant
women an ultrasound examination at 20 weeks’ gestation.
The government’s initial decision not to incorporate
routine ultrasound screening into clinical practice resulted
in large practice variations, i.e., some women having no
ultrasound examination at all, while others having a two-scan
policy or a ‘pleasure scan’ in a commercial setting. The latter
may give false reassurance as these ultrasound examinations
are not intended for the detection of fetal abnormalities
[11, 15]. Until recently, there were neither formal guidelines
for the timing of the ultrasound and counselling nor for
qualifications of sonographers. So even if women have had
one or multiple ultrasound examinations, potentially detect-
able major fetal abnormalities were still missed.
Psychological effects of normal ultrasound
Normal findings at ultrasound examination have strong
beneficial psychological effects on the pregnant woman and
her partner. For couples, ultrasound is a way of ‘meeting’
the unborn child1 [16–19]. The personalisation of the fetus
enhances both maternal–fetal bonding and bonding of the
pregnant woman and her partner [18, 20, 21]. A normal
ultrasound reassures parents about their pregnancies [20,
22–25]. The positive effects of ultrasound are stronger when
more feedback is provided, such as showing images on an
additional monitor and explaining what can be seen [20, 24].
In fact, fetal ultrasound is highly appreciated by pregnant
women and their partners [19, 25–27]. Most women
consider ultrasound examinations as an integral part of
antenatal care [26]. However, frequently, women lack
information about the purpose of ultrasound examinations
and its technical limitations. As a result, women are often
unprepared for adverse findings [27, 28].
Psychological effects of abnormal ultrasound
The news of abnormal findings of the ultrasound examina-
tion frequently comes unexpectedly and is often intensely
shocking for the would-be parents, in particular, when
major congenital abnormalities are encountered [27, 29].
Pregnant women and their partners may have several
emotional reactions when fetal abnormalities are revealed.
Firstly, they may have negative feelings typically associated
with psychological traumas in general, such as anxiety,
grief, anger, loneliness, hopelessness, prostration and guilt
[28–30, 32, 33]. These feelings may be aggravated by the
loss of the imagined future, as the pregnancy may end in the
daily reality of having no child or a severely handicapped
child, requiring readjustments of the entire family. These
negative feelings can be enhanced by the confrontation with
reality, when having to decide about very pragmatic issues
‘should I furnish the nursery?’, ‘should I make arrangements
for the funeral?’, and ‘what should I tell my other child?’.
Finally, some parents experience a loss of reference. The
news of a fetal abnormality in an apparently uneventful
pregnancy usually comes so unexpectedly, and is in such
contrast with the pleasant experiences that often goes along
with pregnancy, that parents have severe difficulty with
grasping the facts. It seems so unreal that the child, who is
kicking inside the womb, is severely disabled and will
perhaps die, thereby making life meaningless. When par-
ents consider pregnancy termination, the ambivalent feel-
ings they experience may enhance this loss of reference.
On the one hand, they are committed to their—desired and
intended—pregnancy while on the other hand they want to
protect their child, themselves and the family from the
burden of severe disability [34].
End-of-life decisions after ultrasound diagnosis
of fetal abnormality
With the burgeoning of ultrasound, questions around the
appropriate obstetric management in case of sonographi-
cally established fetal abnormalities have arisen. Should we
apply all means to keep alive a fetus with a very poor
prognosis? Do medical professionals in the field of
perinatal medicine agree on fetal prognosis after ultrasound
1 A couple’s reaction to a normal ultrasound: ‘The baby becomes more
real... once you see the scan, that all changes. It's no longer your
imagination at work, but you have this real image of a baby. You can
see so much detail... it is amazing, his little fingers and toes, his eyes,
oh, everything. It is magical, so awe inspiring to see’ Puddifoot JE,
Johnson MP. The legitimacy of grieving: the partner’s experience at
miscarriage. Soc Sci Med 1997;45:837-45.
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diagnosis of fetal abnormality? How should obstetric and
neonatal management be attuned? How do parents view
end-of-life decisions concerning their unborn infant? These
and other issues have opened a new field of research: end-
of-life decision-making after ultrasound diagnosis of fetal
abnormality. End-of-life decisions are decisions about
medical interventions at the end of life, which certainly or
probably hasten death [35].
Two kinds of end-of-life decisions can be distinguished
after ultrasound diagnosis of fetal abnormality. That is, (1)
non-aggressive obstetric management and (2) termination of
pregnancy. A non-aggressive obstetric management refers to
an obstetric management in which interventions needed to
sustain fetal life are forgone because of the poor prognosis of
the fetus concerned. Chervenak and McCullough [36] first
reported the non-aggressive obstetric management approach
in 1989. They described 13 cases where such approach was
adopted. They regarded a non-aggressive obstetric manage-
ment as permissible, and even preferable, when there is
certainty of death or absence of cognitive developmental
capacity as outcome of the congenital abnormality. They
argued that, in such cases, the fetus does not benefit from
obstetric intervention, while such intervention may harm
the pregnant woman and interfere with her autonomy [36,
37]. However, empirical data needed for a balanced
professional and societal debate about forgoing fetal life-
sustaining treatment are scarce [36, 38, 39].
Termination of pregnancy is a management option, in
which the pregnancy is terminated with the explicit
intention of hastening fetal death. Termination of pregnancy
is done by induction of labour, which may be preceded by
fetal intracardial potassium injection. The first termination
of pregnancy after ultrasound diagnosis of fetal abnormality
was reported in 1972 by Campbell et al. [40]. Their report
concerned a fetus with anencephaly. Termination of
pregnancy has far-reaching implications for the couple. It
bears life-long lasting consequences and evokes strong
emotions of the couples involved [41, 42].
End-of-life decision makings after ultrasound diagnosis
of fetal abnormality have to take into account both the
interest of the fetus and the pregnant woman. Therefore,
these difficult decisions are usually made by multidisci-
plinary teams [43–47]. These typically consist of obstetri-
cians, neonatologists, paediatric surgeons and other
paediatric specialists, such as paediatric urologists, paedi-
atric neurologists and paediatric neurosurgeons [43–47].
However, little is known about how exactly decisions are
being taken in these teams.
Parental decision making after ultrasound diagnosis of
fetal abnormality remains a largely unknown territory.
Table 1 shows the studies to date, which evaluate
determinants of parental decision regarding termination of
pregnancy. Low gestational age, severe abnormality,
involvement of the central nervous system, previous
uncompleted pregnancies, low maternal educational level
and the presence of chromosomal abnormalities are
associated with high rates of women deciding for termina-
tion of pregnancy. However, these data are not conclusive
and do not reflect why and in what way some factors are
important for the parents. Sandelowski and Jones [48]
studied parental decision making concerning prenatal
diagnosis of fetal abnormality in more depth. She inter-
viewed 15 women and 12 of their partners. Her study
showed that women have highly variable perceptions of
choice. In fact, women in comparable circumstances feel
differently about whether or not they have a choice about
the future of their pregnancy [48].
Legal context and current guidelines
In The Netherlands, law prohibits termination of pregnancy
at a gestational age of 24 weeks or beyond. However, in
case of good clinical practice, physicians will not be
prosecuted by the public prosecutor [49–51]. Good clinical
practice is described in guidelines that were made by a
collaborative group of the Ministry of Health, Ministry of
Justice and the Dutch Society of Obstetricians and
Gynaecologists. According to these guidelines, when
parents persist in their request for termination of pregnancy,
this will be granted when fetal prognosis is considered
lethal. Fetal prognosis is considered lethal if (1) the infant
has no chance of survival and the abnormalities cannot be
treated or (2) the infant has a chance of extra-uterine
survival but post-natal use of life-prolonging medical
treatment is considered futile [50].
In conclusion
In most industrialised countries ultrasonography for the
detection of fetal structural abnormalities has become an
integral part of antenatal care. In general, women are often
ill prepared for bad news about the health of their unborn
child. Upon the detection of severe fetal abnormalities, they
could be faced with decisions whether or not to continue
pregnancy. This essay explores the context of decision
making after ultrasound diagnosis of fetal abnormality, with
emphasis on the Dutch situation. In the case of fetal
abnormalities, perception of choice among pregnant women
varies markedly, challenging the counselling strategy.
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